Iron overload: what's TIMP-3 got to do with it.
Iron overload: what's TIMP-3 got to do with it.
复制标题
铁过载:TIMP-3 与此有何关系。
DOI:
10.1152/ajpheart.00161.2018
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
DeLeon-Pennell,KristineY
中科院分区:
文献类型:
--
作者:
Bradshaw,AmyD;DeLeon-Pennell,KristineY
Physiology-Heart and Circulatory Physiology, Zhabyeyev et al.(10) investigated the role of tissue inhibitor of metalloproteinase (TIMP)-3 in the setting of iron overload. Chronic iron overload results in excess body iron accumulating in multiple organ systems including the liver, spleen, and heart, causing damage to these organs. Accumulation of iron in the myocardium results in iron overload cardiomyopathy, which is the leading cause of death in patients receiving chronic blood transfusion therapy (4). In murine models such as the one used by Zhabyeyev et al., iron overload cardiomyopathy is associated with oxidative stress, fibrosis, and diastolic dysfunction but does not present with excessive inflammation or with systolic dysfunction typically seen in human patients with iron overload. Hence, one shortcoming of the murine model in terms of recapitulating human disease is a lack of a systolic dysfunction component. Interestingly, the lack of TIMP-3 expression in mice with iron overload resulted in a reduction in systolic function compared with wild-type (WT) mice. TIMP-3 is expressed in multiple cell types including hepatocytes and stellate cells in the liver and in myocytes, neutrophils, macrophages, endothelial cells, and fibroblasts in the heart (3). Overall levels of TIMP-3 are higher in the heart than in the liver during homeostasis. In the liver, TIMP-3 plays a role in glucose metabolism, hepatic fatty acid oxidation, and cholesterol homeostasis (2). In the heart, absence of TIMP-3 results in dilated cardiomyopathy at 16 mo of age. Timp3 J/J mice subjected to pressure overload hypertrophy also exhibit accelerated cardiac dilation, which was ameliorated with inhibition of TNF-α activity and inhibition of matrix metalloproteinase (MMP) activity (5). However, the role of TIMP-3 in iron-induced cardiomyopathy is not well understood. Zhabyeyev et al. showed that despite a similar degree of myocardial iron overload, Timp3 J/J animals had decreased systolic function and worsened diastolic function compared with WT mice (10). Cardiac dysfunction in Timp3 J/J mice was mainly attributed to increased fibrosis, MMP activity, and inflammatory state. The authors concluded that TIMP-3 was protective in iron-induced cardiomyopathy, and potential mechanisms proposed included the modulation of macrophage differentiation from the M1 to M2 phenotype, decreased TNF-α shedding in the liver, and/or attenuation of the actions of MMPs. An interesting aspect of the Zhabyeyev et al. study (10) was the comparison of hepatic versus cardiac response to iron overload in the absence of TIMP-3 expression, particularly in terms of inflammation and MMP expression (Table 1). Although there was a notable increase in cellular inflammation in the iron-overloaded liver that was further increased in Timp3 J/J mice, increases in inflammatory cell populations were not detected in iron-overloaded hearts in either WT or Timp3 J/J mice. The absence of TIMP-3 in the iron-overloaded heart was associated with greater expression of TIMP-1 and TIMP-2, increased gelatinase activity, and increased fibrosis versus levels in WT mice, factors likely contributing to the greater level of cardiac dysfunction in Timp3 J/J mice with iron overload. In contrast, the greater number of neutrophils and macrophages in the Timp3 J/J liver with iron overload was not associated with significant increases in MMP-2, MMP-9, or gelatinase activity compared with corresponding WT liver. The differential response of these two organs suggests that in the heart, TIMP-3 plays a greater role in modulating TIMP and MMP expression by resident cells over that of increases in inflammatory cells, whereas in the liver, the function of …